drugset / Trial / NCT05128916

Efficacy of Intralesional PRP in Treatment of Onychomycosis

NCT05128916

Phase 3 Unknown 75 enrolled Sohag University
RandomizedParallel-groupSingle-blindTreatment

Summary

This study aims to investigate efficacy of intralesional PRP in treatment of finer nail onychomycosis.

Timeline

Start
2021-12-01
Primary completion
2022-06-01
Completion
2022-09-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Platelet Rich Plasma Other / unclassified Other
Comparator Terbinafine Small molecule 250 mg Oral

Indications

No indication recorded.